Blog Posts Relating to:
CMS
MIPS 2019 – Summary of the Biggest Changes to the 2019 Final Rule (vs. 2018)
MIPS 2019 is here. It may seem too soon, as some clinicians are still finishing their reporting for the MIPS 2018 performance year. However, the time has come. The Quality performance category requires clinicians to report a full year’s worth of data. So, the sooner providers start, the better.
To help you get going quickly, we’ve summarized the biggest changes to the MIPS 2019 Final Rule, as compared to 2018.
As this is the third year of MIPS, the requirements have increased, along with the potential penalties. The CMS is raising the stakes, so to speak. However, clinicians can still avoid negative payment adjustments without too heavy a burden. While the demands have technically doubled for 2019, providers still only need to score 30 out of 100 possible points to escape penalty. That’s certainly doable.
MIPS Participation Guide for 2018
The purpose of this post is to walk you everything you need to know in order to successfully participate in MIPS for the 2018 performance year. Whether you’re relatively fluent in MIPS or a complete beginner, we hope you’ll leave with a general understanding of the MIPS system and what’s required of you.
If you’re completely new to MIPS, check out the following links before reading the remainder of this article.
- Our MIPS Page: Contains a general explanation of MIPS, along with information about who must participate in 2018, the evaluation criteria (Performance Categories), and Reporting Options for providers
- MIPS 2018 Overview and Assistance: A blog post containing information about MIPS 2018 eligibility, exemptions, and logistics
Lobbying for our Clients: Valletta’s Trip to Capitol Hill
On the final day of HBMA’s 2017 Compliance Symposium, a few of us at The Valletta Group had the opportunity to meet with members of Congress to discuss various healthcare issues. It’s no secret that healthcare policy is currently in a state of volatility. In times of heated debate such as this, often only the most serious and divisive issues receive attention. Unfortunately, this can cause lesser-known, yet equally important issues to get overlooked.
Thus, the time is critical for RCM companies like ourselves to further relationships with our leaders and stand up for the policies that protect our clients and their patients. So when The Valletta Group and other HBMA members visited Capitol Hill, we spoke up for these lesser-known, bipartisan issues. These are the policies that help ensure a level playing field between insurance payers and physicians/patients.
Two of these issues are discussed below.
The Valletta Group’s Executive VP’s, Gilbert Johnston and Cal LaGroue, meet with United States Senator, Luther Strange.
